PRESS RELEASE published on 08/13/2024 at 22:30, 1 year 7 months ago Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada MedMira Inc. announces full clinical trials for Multiplo® Complete Syphilis (TP/nTP) Antibody Test in Canada with REACH Nexus at MAP Centre for Urban Health Solutions. The innovative test combines screening and confirmation in under 3 minutes Clinical Trials MedMira Inc. Syphilis REACH Nexus Multiplo® TP/nTP
BRIEF published on 07/03/2024 at 05:05, 1 year 8 months ago MedMira publie ses résultats du troisième trimestre de l'exercice 2024 Résultats Financiers MedMira T3 De L'exercice 2024 Révéler® G4 Partenaires De Distribution
BRIEF published on 07/03/2024 at 05:05, 1 year 8 months ago MedMira Reports Third Quarter Results FY2024 Financial Results MedMira Q3 FY2024 Reveal® G4 Distribution Partners
PRESS RELEASE published on 07/03/2024 at 05:00, 1 year 8 months ago MedMira Reports Third Quarter Results FY2024 MedMira Inc. reports Q3 FY2024 financial results including revenue, gross profit, operating expenses, net loss, and balance sheet highlights. Company focuses on US FDA approved HIV test and new clinical trials in Canada Financial Results Clinical Trials MedMira Inc. Q3 FY2024 HIV Test
BRIEF published on 05/01/2024 at 04:05, 1 year 10 months ago MedMira nomme un nouveau vice-président du développement commercial Stratégie De Croissance MedMira Développement Des Affaires Rene Bell Marché Américain De La Santé
BRIEF published on 05/01/2024 at 04:05, 1 year 10 months ago MedMira Appoints New Vice President of Business Development Growth Strategy Business Development MedMira Rene Bell US Healthcare Market
PRESS RELEASE published on 05/01/2024 at 04:00, 1 year 10 months ago MedMira Announces the Hire of Vice President of Business Development MedMira Inc. expands commercialisation team, appoints Rene Bell as Vice President of Business Development. Bell to focus on sales growth and partnerships in the US market Sales Business Development US Market MedMira Inc. Rene Bell
BRIEF published on 04/02/2024 at 04:35, 1 year 11 months ago MedMira rend compte des résultats financiers et de l'évolution de l'activité du deuxième trimestre de l'exercice 2024 Résultats Financiers Hausse Des Revenus Autorisation De La FDA MedMira Santé Canada
BRIEF published on 04/02/2024 at 04:35, 1 year 11 months ago MedMira Reports on Q2 FY2024 Financial Results and Business Developments Financial Results Revenue Growth FDA Clearance Health Canada MedMira
PRESS RELEASE published on 04/02/2024 at 04:30, 1 year 11 months ago MedMira Reports Second Quarter Results FY2024 MedMira Inc. reports Q2 FY2024 financial results & milestones achieved including US FDA 510(k) clearance for Reveal® G4 Rapid HIV-1/2 test Financial Results MedMira Inc. Q2 FY2024 US FDA 510(k) Reveal® G4 Rapid HIV-1/2
Published on 03/23/2026 at 22:40, 2 hours 14 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 2 hours 24 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 2 hours 54 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 3 hours 36 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 10 hours 49 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/24/2026 at 00:09, 44 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 2 hours 48 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 3 hours 49 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 3 hours 49 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 3 hours 53 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 19:08, 5 hours 46 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 5 hours 46 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 6 hours 16 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 7 hours 9 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 7 hours 9 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
